TickerFactsScreenerDevelopers

ImmunityBio, Inc. (IBRX) — Revenue

Annual figures by fiscal year, from SEC filings.

2013: $600.0K2014: $641.0K2015: $236.0K2016: $44.0K2017: $45.0K2018: $47.0K2019: $2.20M2020: $605.0K2021: $934.0K2022: $240.0K2023: $622.0K2024: $14.74M2025: $113.29M$113.29M
2013Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$113.29M+668.3%
2024$14.74M+2270.6%
2023$622.0K+159.2%
2022$240.0K-74.3%
2021$934.0K+54.4%
2020$605.0K-72.5%
2019$2.20M+4585.1%
2018$47.0K+4.4%
2017$45.0K+2.3%
2016$44.0K-81.4%
2015$236.0K-63.2%
2014$641.0K+6.8%
2013$600.0K—